Healthcare -
Biotechnology - NASDAQ - US
$ 9.78
-1.71 %
$ 135 M
Market Cap
-195.6
P/E
CSBR - COST OF REVENUE
Cost of Revenue CSBR - Champions Oncology, Inc.
29.4 M
LAST VALUE
11.54%
2 YEAR CAGR
15.56%
5 YEAR CAGR
16.72%
10 YEAR CAGR